Stock Photo - 03 February 2022, Thuringia, Jena: Simon Madej, managing director of Axenoll 3D Printing GmbH. Axenoll produces sterile cellular and non-cellular biological pharmaceutical, biotechnological and medical products in a mass 3D printing process. On the same day, the Thuringia Business Association will present the 2022 survey of Thuringia's employers' and business associations on the economic development of the Free State. Photo: Martin Schutt/dpa-Zentralbild/dpa. - Jena/Thuringia/Germany

Comp Image

You may use this image, for up to 30 days following download (Evaluation Period), for your internal review and evaluation only (layouts and comps) in order to determine if it meets the necessary requirements for the intended use.This authorization does not allow you to make any use in final materials or products or make it available to third parties for use or distribution by any means. If at the end of the Evaluation Period you do not contract a license for its use, you must stop using the image and destroy / delete any copy of it.

Stop showing this message